CareStart rapid antigen tests are US-made and TGA approved for use in Australia. The test identifies acute COVID infection with high sensitivity and 100% specificity.
Antigen tests that are supplied either on their own or as part of our outbreak response kits must be used under the supervision of a qualified health professional – Respond Global can provide staff if required.
Antigen testing will enable businesses to continue to operate through future waves of COVID. For remote and high-risk settings particularly this is the game-changer we’ve been waiting for.